Clinical Trials

- Show Actively Recruiting Trials Only        
Status Title Condition(s) Last Updated
Active, not recruiting The Pivotal Study of the Aptus Endovascular AAA Repair System    
More Info From ClinTrials.gov
Abdominal Aortic Aneurysms (AAA) Feb 14, 2012
Active, not recruiting A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery    
More Info From ClinTrials.gov
Post Abdominal Surgery Pain Feb 25, 2016
Recruiting 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease    
More Info From ClinTrials.gov
Alzheimer's Disease Apr 21, 2016
Recruiting Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes    
More Info From ClinTrials.gov
Diabetes Feb 25, 2016
Recruiting Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry    
More Info From ClinTrials.gov
Rheumatic Joint Disease Jan 19, 2016
Recruiting Hemodialysis Access Surveillance Evaluation Study    
More Info From ClinTrials.gov
Hemodialysis Access; Thrombosis Feb 4, 2016
Recruiting ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study    
More Info From ClinTrials.gov
Atrial Septal Defect Secundum Feb 11, 2016
Active, not recruiting Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)    
More Info From ClinTrials.gov
HIV-1 Infection Sep 24, 2015
Active, not recruiting Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults    
More Info From ClinTrials.gov
HIV-1 Infection Sep 24, 2015
Active, not recruiting Clearing Lungs With ENAC Inhibition in Cystic Fibrosis    
More Info From ClinTrials.gov
Cystic Fibrosis Mar 1, 2016
Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021    
More Info From ClinTrials.gov
Huntington's Disease Apr 12, 2016
Active, not recruiting Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes    
More Info From ClinTrials.gov
Diabetes Mellitus Mar 14, 2016
Recruiting Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes    
More Info From ClinTrials.gov
Type 1 Diabetes Mellitus Feb 25, 2016
Recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease    
More Info From ClinTrials.gov
Huntington's Disease Apr 12, 2016
Active, not recruiting Efficacy of Isradipine in Early Parkinson Disease    
More Info From ClinTrials.gov
Parkinson Disease Apr 4, 2016
Active, not recruiting Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults    
More Info From ClinTrials.gov
HIV-1; HIV Infections; Acquired Immunodeficiency Syndrome Feb 22, 2016
Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)    
More Info From ClinTrials.gov
Pulmonary Arterial Hypertension Apr 15, 2016
Active, not recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo    
More Info From ClinTrials.gov
Alzheimer's Disease Mar 29, 2016
Completed An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165    
More Info From ClinTrials.gov
Phenylketonuria Nov 25, 2015
Active, not recruiting Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment    
More Info From ClinTrials.gov
HIV; HIV Infections Jan 21, 2016
Active, not recruiting Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants    
More Info From ClinTrials.gov
HIV; HIV Infections Mar 15, 2016